All Title Author
Keywords Abstract

PLOS ONE  2012 

Consent for Use of Clinical Leftover Biosample: A Survey among Chinese Patients and the General Public

DOI: 10.1371/journal.pone.0036050

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background Storage of leftover biosamples generates rich biobanks for future studies, saving time and money and limiting physical impact to sample donors. Objective To investigate the attitudes of Chinese patients and the general public on providing consent for storage and use of leftover biosamples. Design, Setting and Participants Cross-sectional surveys were conducted among randomly selected patients admitted to a Shanghai city hospital (n = 648) and members of the general public (n = 492) from May 2010 to July 2010. Main Outcome Measures Face-to-face interviews collected respondents-report of their willingness to donate residual biosample, trust in medical institutions, motivation for donation, concerns of donated sample use, expectations for research results return, and so on. Results The response rate was 83.0%. Of the respondents, 89.1% stated that they completely understood or understood most of questions. Willingness to donate residual sample was stated by 64.7%, of which 16.7% desired the option to withdraw their donations anytime afterwards. Only 42.3% of respondents stated they “trust" or “strongly trust" medical institutions, the attitude of trusting or strongly trusting medical institutions were significantly associated with willingness to donate in the general public group.(p<0.05) The overall assent rate for future research without specific consents was also low (12.1%). Hepatitis B virus carriers were significantly less willing than non-carriers to donate biosamples (32.1% vs. 64.7%, p<0.001). Conclusions Low levels of public trust in medical institutions become serious obstacle for biosample donation and biobanking in China. Efforts to increase public understanding of human medical research and biosample usage and trust in the ethical purposes of biobanking are urgently needed. These efforts will be greatly advanced by the impending legislation on biobanking procedures and intent, and our results may help guide the structure of such law.

References

[1]  Elger BS, Caplan AL (2006) Consent and anonymization in research involving biobanks: differing terms and norms present serious barriers to an international framework. EMBO Rep 7: 661–666.
[2]  Hansson MG, Dillner J, Bartram CR, Carlson JA, Helgesson G (2006) Should donors be allowed to give broad consent to future biobank research? Lancet Oncol 7: 266–269.
[3]  Chen DT, Rosenstein DL, Muthappan P, Hilsenbeck SG, Miller FG, et al. (2005) Research with stored biological samples: what do research participants want? Arch Intern Med 165: 652–655.
[4]  Wendler D (2006) One-time general consent for research on biological samples. BMJ 332: 544–547.
[5]  Hansson MG (2009) Ethics and biobanks. Br J Cancer 100: 8–12.
[6]  Kaufman DJ, Murphy-Bollinger J, Scott J, Hudson KL (2009) Public opinion about the importance of privacy in biobank research. Am J Hum Genet 85: 643–654.
[7]  Forsberg JS, Hansson MG, Eriksson S (2009) Changing perspectives in biobank research: from individual rights to concerns about public health regarding the return of results. Eur J Hum Genet 17: 1544–1549.
[8]  Wendler D, Emanuel E (2002) The debate over research on stored biological samples: what do sources think? Arch Intern Med 162: 1457–1462.
[9]  Campbell AV (2007) The ethical challenges of genetic databases: safeguarding altruism and trust. Kings Law J 18: 227–245.
[10]  McHale J, Habiba M, Dixon-Woods M, Cavers D, Heney D, et al. (2007) Consent for childhood cancer tissue banking in the UK: the effect of the Human Tissue Act 2004. Lancet Oncol 8: 266–272.
[11]  Kiehntopf M, Krawczak M (2011) Biobanking and international interoperability: samples. Hum Genet 130: 369–376.
[12]  Salvaterra E, Lecchi L, Giovanelli S, Butti B, Bardella MT, et al. (2008) Banking together. A unified model of informed consent for biobanking. EMBO Rep 9: 307–313.
[13]  Knoppers BM, Abdul-Rahman MH, Bédard K (2007) Genomic databases and international collaboration. Kings Law J 18: 291–311.
[14]  Jefford M, Moore R (2008) Improvement of informed consent and the quality of consent documents. Lancet Oncol 9: 485–493.
[15]  Fitzpatrick PE, McKenzie KD, Beasley A, Sheehan JD (2009) Patients attending tertiary referral urology clinics: willingness to participate in tissue banking. BJU Int 104: 209–213.
[16]  Vermeulen E, Schmidt MK, Aaronson NK, Kuenen M, Baas-Vrancken Peeters MJ, et al. (2009) A trial of consent procedures for future research with clinically derived biological samples. Br J Cancer 101: 1505–1512.
[17]  Tupasela A, Sihvo S, Snell K, Jallinoja P, Aro AR, et al. (2010) Attitudes towards biomedical use of tissue sample collections, consent, and biobanks among Finns. Scand J Public Health 38: 46–52.
[18]  Matsui K, Kita Y, Ueshima H (2005) Informed consent, participation in, and withdrawal from a population-based cohort study involving genetic analysis. J Med Ethics 31: 385–392.
[19]  Wendler D, Pace C, Talisuna A, Maiso F, Grady C, et al. (2005) Research on stored biological samples: the views of Ugandans. IRB Ethics Hum Res 27: 1–5.
[20]  Wang SS, Fridinger F, Sheedy KM, Khoury MJ (2001) Public attitudes regarding the donation and storage of blood specimens for genetic research. Community Genet 4: 18–26.
[21]  Tutton R, Kaye J, Hoeyer K (2004) Governing UK Biobank: the importance of ensuring public trust. Trends Biotechnol 22: 284–285.
[22]  Fan M (2008) Health care tops list of concerns in China. Washington Post (Washington, DC). January 10:
[23]  Hu S, Tang S, Liu Y, Zhao Y, Escobar ML, et al. (2008) Reform of how health care is paid for in China: challenges and opportunities. Lancet 372: 1846–1853.
[24]  Wagstaff A, Yip W, Lindelow M, Hsiao WC (2009) China's health system and its reform: a review of recent studies. Health Econ 18: Suppl 27S–23S.
[25]  [editorial] (2010) Chinese doctors are under threat. Lancet 376: 657.
[26]  Willison DJ, Steeves V, Charles C, Schwartz L, Ranford J, et al. (2009) Consent for use of personal information for health research: do people with potentially stigmatizing health conditions and the general public differ in their opinions? BMC Med Ethics 10: 10.
[27]  Shan J (2007) China has 120 m hepatitis B carriers. China Daily. September 1.
[28]  Malone T, Catalano PJ, O'Dwyer PJ, Giantonio B (2002) High rate of consent to bank biologic samples for future research: the Eastern Cooperative Oncology Group experience. J Natl Cancer Inst 94: 769–771.
[29]  Henderson G, Garrett J, Bussey-Jones J, Moloney ME, Blumenthal C, et al. (2008) Great expectations: views of genetic research participants regarding current and future genetic studies. Genet Med 10: 193–200.

Full-Text

comments powered by Disqus